186 related articles for article (PubMed ID: 7906293)
1. Serum levels of tumor necrosis factor-alpha (TNF alpha) and soluble TNF receptors in human immunodeficiency virus type 1 infection--correlations to clinical, immunologic, and virologic parameters.
Aukrust P; Liabakk NB; Müller F; Lien E; Espevik T; Frøland SS
J Infect Dis; 1994 Feb; 169(2):420-4. PubMed ID: 7906293
[TBL] [Abstract][Full Text] [Related]
2. Tumor necrosis factor alpha and soluble tumor necrosis factor receptors in individuals with human immunodeficiency virus infection.
Zangerle R; Gallati H; Sarcletti M; Wachter H; Fuchs D
Immunol Lett; 1994 Jul; 41(2-3):229-34. PubMed ID: 8002043
[TBL] [Abstract][Full Text] [Related]
3. Soluble tumor necrosis factor receptors as surrogate markers for the assessment of zidovudine treatment in asymptomatic HIV-1 infection.
Godfried MH; van der Poll T; Mulder JW; Weverling GJ; Endert E; Lange JM; Sauerwein HP
J Acquir Immune Defic Syndr Hum Retrovirol; 1995 Dec; 10(5):531-9. PubMed ID: 8548332
[TBL] [Abstract][Full Text] [Related]
4. Increased concentrations of soluble tumor necrosis factor receptor 75 but not of soluble intercellular adhesion molecule-1 are associated with the decline of CD4+ lymphocytes in HIV infection.
Zangerle R; Fuchs D; Sarcletti M; Gallati H; Reibnegger G; Wachter H; Dierich MP; Möst J
Clin Immunol Immunopathol; 1994 Sep; 72(3):328-34. PubMed ID: 7914841
[TBL] [Abstract][Full Text] [Related]
5. Predictive value for survival of soluble tumor necrosis factor receptors p55 and p75 during zidovudine-containing treatment in symptomatic human immunodeficiency virus type 1 infection.
Frissen PH; Weverling GJ; Endert E; Jansen J; Sauerwein HP; Lange JM
J Acquir Immune Defic Syndr Hum Retrovirol; 1996 Aug; 12(5):482-8. PubMed ID: 8757425
[TBL] [Abstract][Full Text] [Related]
6. Activation of tumor necrosis factor--alpha system in HIV-1 infection: association with markers of immune activation.
Aukrust P; Liabakk NB; Müller F; Espevik T; Frøland SS
Infection; 1995; 23(1):9-15. PubMed ID: 7744500
[TBL] [Abstract][Full Text] [Related]
7. [Serum levels of soluble tumor necrosis factor receptors as markers for disease progression of human immunodeficiency virus infection].
Hattori M; Tateyama M; Oishi T; Miyasaka S; Fukutake K
Rinsho Byori; 1997 Nov; 45(11):1085-90. PubMed ID: 9396350
[TBL] [Abstract][Full Text] [Related]
8. Dysregulation of membrane-bound tumor necrosis factor-alpha and tumor necrosis factor receptors on mononuclear cells in human immunodeficiency virus type 1 infection: low percentage of p75-tumor necrosis factor receptor positive cells in patients with advanced disease and high viral load.
Hestdal K; Aukrust P; Müller F; Lien E; Bjerkeli V; Espevik T; Frøland SS
Blood; 1997 Oct; 90(7):2670-9. PubMed ID: 9326234
[TBL] [Abstract][Full Text] [Related]
9. Soluble receptors for tumor necrosis factor are markers for clinical course but not for major metabolic changes in human immunodeficiency virus infection.
Godfried MH; Romijn JA; van der Poll T; Weverling GJ; Corssmit EP; Endert E; Eeftinck Schattenkerk JK; Sauerwein HP
Metabolism; 1995 Dec; 44(12):1564-9. PubMed ID: 8786725
[TBL] [Abstract][Full Text] [Related]
10. The prognostic value of cellular and serologic markers in infection with human immunodeficiency virus type 1.
Fahey JL; Taylor JM; Detels R; Hofmann B; Melmed R; Nishanian P; Giorgi JV
N Engl J Med; 1990 Jan; 322(3):166-72. PubMed ID: 1967191
[TBL] [Abstract][Full Text] [Related]
11. Plasma levels of soluble CD30, tumour necrosis factor (TNF)-alpha and TNF receptors during primary HIV-1 infection: correlation with HIV-1 RNA and the clinical outcome.
Rizzardi GP; Barcellini W; Tambussi G; Lillo F; Malnati M; Perrin L; Lazzarin A
AIDS; 1996 Nov; 10(13):F45-50. PubMed ID: 8931778
[TBL] [Abstract][Full Text] [Related]
12. Soluble tumor necrosis factor-alpha receptor type II (sTNF alpha RII) correlates with human immunodeficiency virus (HIV) RNA copy number in HIV-infected patients.
Bilello JA; Stellrecht K; Drusano GL; Stein DS
J Infect Dis; 1996 Feb; 173(2):464-7. PubMed ID: 8568313
[TBL] [Abstract][Full Text] [Related]
13. Neopterin and human immunodeficiency virus infection.
Hofmann B
Eur J Clin Chem Clin Biochem; 1993 Apr; 31(4):191-5. PubMed ID: 8100453
[TBL] [Abstract][Full Text] [Related]
14. Serum concentrations of circulating endogenous granulocyte-macrophage colony-stimulating factor in HIV-1-seropositive injecting drug users.
Herold M; Meise U; Günther V; Rössler H; Zangerle R
Presse Med; 1994 Dec; 23(40):1854-8. PubMed ID: 7899316
[TBL] [Abstract][Full Text] [Related]
15. Increased serum concentrations of soluble tumor necrosis factor receptors in HIV-infected individuals are associated with immune activation.
Zangerle R; Gallati H; Sarcletti M; Weiss G; Denz H; Wachter H; Fuchs D
J Acquir Immune Defic Syndr (1988); 1994 Jan; 7(1):79-85. PubMed ID: 7903382
[TBL] [Abstract][Full Text] [Related]
16. Serum nitrite plus nitrate in infection with human immunodeficiency virus type-1.
Zangerle R; Fuchs D; Reibnegger G; Werner-Felmayer G; Gallati H; Wachter H; Werner ER
Immunobiology; 1995 Jun; 193(1):59-70. PubMed ID: 7590863
[TBL] [Abstract][Full Text] [Related]
17. Soluble receptors for tumour necrosis factor: a putative marker of disease progression in HIV infection.
Godfried MH; van der Poll T; Jansen J; Romijin JA; Schattenkerk JK; Endert E; van Deventer SJ; Sauerwein HP
AIDS; 1993 Jan; 7(1):33-6. PubMed ID: 8382926
[TBL] [Abstract][Full Text] [Related]
18. Serum levels of IL-2, IL-1 alpha, TNF-alpha, and soluble receptor of IL-2 in HIV-1-infected patients.
Scott-Algara D; Vuillier F; Marasescu M; de Saint Martin J; Dighiero G
AIDS Res Hum Retroviruses; 1991 Apr; 7(4):381-6. PubMed ID: 1676897
[TBL] [Abstract][Full Text] [Related]
19. Soluble tumor necrosis factor alpha receptors (sTNF-Rs) in HIV-1-infected intravenous drug users: change in circulating sTNF-R type II level and survival for AIDS patients.
Ajello F; La Licata R; Lodato M; Vitale F; Bonura F; Valenti R; Bruno M; Romano N
Eur J Epidemiol; 2000 Mar; 16(3):209-16. PubMed ID: 10870934
[TBL] [Abstract][Full Text] [Related]
20. Serum HIV-1 RNA levels compared to soluble markers of immune activation to predict disease progression in HIV-1-infected individuals.
Zangerle R; Steinhuber S; Sarcletti M; Dierich MP; Wachter H; Fuchs D; Möst J
Int Arch Allergy Immunol; 1998 Jul; 116(3):228-39. PubMed ID: 9693271
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
